Benzinga · Nov 13, 2026
Freedom Broker Maintains Buy on Lifevantage, Lowers Price Target to $8
Freedom Broker analyst Ilya Zubkov maintains Lifevantage (NASDAQ:LFVN) with a Buy and lowers the price target from $9 to $8.
NYSE · LFVN
Consumer Defensive · Packaged Foods
$4.15
Down-$0.74 (-15.13%)
Updated Nov 21, 2026, 4:32 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · LFVN
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 20, 2026
LFVN closed at $4.15 after 21 trading sessions, down 29.18% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | $4.84 | $4.9299 | $4.00 | $4.15 | 72.94K |
| Nov 19, 2026 | $4.80 | $5.00 | $4.7001 | $4.89 | 92.86K |
| Nov 18, 2026 | $4.78 | $5.00 | $4.64 | $4.81 | 136.89K |
| Nov 17, 2026 | $4.82 | $4.97 | $4.73 | $4.78 | 89.37K |
| Nov 16, 2026 | $4.94 | $5.20 | $4.67 | $4.77 | 118.38K |
| Nov 13, 2026 | $4.96 | $5.24 | $4.76 | $4.97 | 111.49K |
| Nov 12, 2026 | $4.87 | $5.25 | $4.72 | $5.04 | 183.64K |
| Nov 11, 2026 | $4.63 | $5.06 | $4.63 | $4.72 | 57.38K |
| Nov 10, 2026 | $5.13 | $5.305 | $4.56 | $4.56 | 44.1K |
| Nov 9, 2026 | $5.22 | $5.54 | $5.22 | $5.29 | 31.19K |
| Nov 6, 2026 | $5.11 | $5.32 | $5.09 | $5.22 | 24.27K |
| Nov 5, 2026 | $5.91 | $6.0539 | $5.05 | $5.05 | 27.33K |
| Nov 4, 2026 | $5.77 | $6.07 | $5.77 | $5.97 | 20.57K |
| Nov 3, 2026 | $5.86 | $5.91 | $5.75 | $5.76 | 28.2K |
| Nov 2, 2026 | $5.84 | $6.03 | $5.84 | $5.87 | 17.23K |
| Oct 30, 2026 | $5.87 | $5.90 | $5.78 | $5.88 | 24.07K |
| Oct 29, 2026 | $5.8736 | $6.00 | $5.83 | $5.87 | 14.63K |
| Oct 28, 2026 | $5.89 | $5.95 | $5.7846 | $5.89 | 11.25K |
| Oct 27, 2026 | $5.78 | $5.99 | $5.78 | $5.93 | 16.45K |
| Oct 26, 2026 | $5.76 | $5.7783 | $5.5274 | $5.76 | 24.23K |
| Oct 23, 2026 | $5.96 | $5.999 | $5.61 | $5.86 | 23.75K |
The latest Smart Investors Daily articles mentioning LFVN.
Company
Market Activity
Research & News
LFVN research
Company profile and research snapshot.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 13, 2026 | Freedom Broker | Buy | — |
| Aug 28, 2026 | Lake Street | Hold | — |
| May 7, 2026 | Lake Street | Hold | — |
| Jan 14, 2025 | Craig-Hallum | Buy | — |
| Dec 19, 2024 | Lake Street | Buy | — |
No generated briefing is available yet.
Benzinga · Nov 13, 2026
Freedom Broker analyst Ilya Zubkov maintains Lifevantage (NASDAQ:LFVN) with a Buy and lowers the price target from $9 to $8.
Yahoo · Nov 10, 2026
Lifevantage Corp (LFVN) posted a $37.1 million quarterly revenue decline but preserved a debt-free balance sheet while investing in a digital overhaul and brand repositioning.
SeekingAlpha · Nov 10, 2026
LifeVantage Corporation (LFVN) Q1 2027 Earnings Call November 9, 2026 4:30 PM ESTCompany ParticipantsTerrence Moorehead - President, CEO & DirectorCarl...
Yahoo · Nov 10, 2026
Moby summary of LifeVantage Corporation's Q1 2027 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning LFVN.